Tumor Biology

, Volume 35, Issue 7, pp 7177–7185 | Cite as

Concomitant upregulation of nucleostemin and downregulation of Sox2 and Klf4 in gastric adenocarcinoma

  • Malek Hossein Asadi
  • Ali Derakhshani
  • Seyed Javad Mowla
Research Article


Nucleostemin (NS) is a nucleolar protein involved in stem cell (SC) self-renewal by controlling cell cycle progression. In addition to SCs, NS is also expressed in some highly proliferating cells including several adult stem cells and cancer cell lines. NS knock-down in different cell lines demonstrated its cell type-dependent function in arresting cell cycle in either G1 or G2/M phases. Here, we have evaluated the expression of NS and iPS genes in 36 gastric cancer and their matched marginal nontumor tissues by means of real-time polymerase chain reaction (RT-PCR). We have also examined a potential causative role of NS in gastric tumorigenesis by suppressing its expression in a gastric cancer cell line, AGS. Our data revealed that NS expression level is much higher in tumor tissues (p = 0.046), especially in high-grade ones (p < 0.001), whereas the expression of Klf4 and Sox2 is downregulated in tumor tissues compared to marginal nontumor samples (p < 0.001). Furthermore, NS suppression in the AGS cell line caused some morphological alterations, a cell cycle arrest at G1 phase, and an upregulation of iPS genes: Nanog, Sox2, and Klf4. Based on our results, NS overexpression seems to have a causative role in gastric tumorigenesis and/or progression, and it could be considered as a potential tumor marker for diagnosis, molecular classification, and molecular therapy of gastric adenocarcinoma.


Nucleostemin Gastric cancer RNAi Cancer stem cell iPS 



We thank Dr. Hamid-Reza Kalhor for his valuable comments. This work was supported, in part, by a research grant from the Iranian stem cell network.

Conflicts of interest



  1. 1.
    Tsai RY, McKay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev. 2002;16:2991–3003.PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem. 2003;89:1235–49.CrossRefPubMedGoogle Scholar
  3. 3.
    Politz JC, Polena I, Trask I, Bazett-Jones DP, Pederson T. A nonribosomal landscape in the nucleolus revealed by the stem cell protein nucleostemin. Mol Biol Cell. 2005;16:3401–10.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Jafarnejad SM, Mowla SJ, Matin MM. Knocking-down the expression of nucleostemin significantly decreases rate of proliferation of rat bone marrow stromal stem cells in an apparently p53-independent manner. Cell Prolif. 2008;41:28–35.CrossRefPubMedGoogle Scholar
  5. 5.
    Kermani AJ, Fathi F, Mowla SJ. Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy. Rejuvenation Res. 2008;11:379–86.CrossRefPubMedGoogle Scholar
  6. 6.
    Tsai RY, McKay RD. A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin. J Cell Biol. 2005;168:179–84.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Du X, Rao MR, Chen XQ, Wu W, Mahalingam S, Bala-sundaram D. The homologous putative GTPases Grn1p from fission yeast and the human GNL3L are required for growth and play a role in processing of nucleolar pre-rRNA. Mol Biol Cell. 2006;17:460–74.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Romanova L, Grand A, Zhang L, Rayner S, Katoku-Kikyo N, Kellner S, et al. Critical role of nucleostemin in pre-rRNA processing. J Biol Chem. 2009;284(8):4968–77.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Zhu Q, Yasumoto H, Tsai RY. Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol Cell Biol. 2006;26:9279–90.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Beckman C, Nichane M, Clercq SD, Maetens M, Floss T, Wurst W, et al. Evolutionary conserved role of nucleostemin: controlling proliferation of stem/progenitor cells during early vertebrate development. Mol Cell Biol. 2006;26:9291–301.CrossRefGoogle Scholar
  11. 11.
    Kafienah W, Mistry S, Williams C, Hollander P. Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow. Stem Cells. 2006;24:1113–20.CrossRefPubMedGoogle Scholar
  12. 12.
    Liu SJ, Cai ZW, Liu YJ, Dong MY, Sun LQ, Hu GF, et al. Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies. World J Gastroenterol. 2004;10:1246–9.PubMedGoogle Scholar
  13. 13.
    Fan Y, Liu Z, Zhao S, Lou F, Nilsson S, Ekman P, et al. Nucleostemin mRNA is expressed in both normal and malignant renal tissues. Br J Cancer. 2006;94:1658–62.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Malakootian M, Mowla SJ, Saberi H, Asadi MH, Atlasi Y, Shafaroudi AM. Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors. Mol Carcinog. 2010;49(9):818–45.PubMedGoogle Scholar
  15. 15.
    Sijin L, Ziwei C, Yajun L, Meiyu D, Hongwei Z, Guofa H, et al. The effect of nocking-down nucleostemin gene expression on the in vitro proliferation and in vivo tumorigenesis of HeLa cells. J Exp Clin Cancer Res. 2004;23:529–38.PubMedGoogle Scholar
  16. 16.
    Ma H, Pederson T. Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway. Mol Biol Cell. 2007;18:2630–5.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Dai MS, Sun XX, Lu H. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol. 2008;28:4365–76.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Nikpour P, Mowla SJ, Jafarnejad SM, Fischer U, Schulz WA. Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710. Cell Prolif. 2009;42:762–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Okamoto N, Yasukawa M, Nguyen C, Kasim V, Maida Y, Possemato R, et al. Maintenance of tumor initiating cells of defined genetic composition by nucleostemin. PNAS. 2011;108:20388–93.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Johansson H, Simonsson S. Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin(Npm1) to control embryonic stem (ES) cell fate determination. Aging. 2010;2(11):815–22.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Janssen K, Pohlmann S, Janicke RU, Schulze-Osthoff K, Fischer U. Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood. 2007;110:3662–72.CrossRefPubMedGoogle Scholar
  22. 22.
    Asadi MH, Mowla SJ, Fathi F, Asadzadeh J, Atlasi Y. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as antiapoptotic factor. Int J Cancer. 2011;128:2645–52.CrossRefPubMedGoogle Scholar
  23. 23.
    Zhang G, Zhang Q, Zhang Q, Yin L, Li S, Cheng K, et al. Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues. J Cancer Res Clin Oncol. 2010;136:587–94.CrossRefPubMedGoogle Scholar
  24. 24.
    Liu RL, Zhang ZH, Zhao WM, Wang M, Qi SY, Li J, et al. Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells. Chin Med J. 2008;121(4):299–304.PubMedGoogle Scholar
  25. 25.
    Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JL, et al. Drastic downregulation of Krüppel-Like Factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005;65:2746–54.CrossRefPubMedGoogle Scholar
  26. 26.
    Wang N, Liu ZH, Ding F, Wang XQ, Zhou CN, Wu M. Down-regulation of gut-enriched Krüppel-like factor expression in esophageal cancer. World J Gastroenterol. 2002;8:966–70.PubMedGoogle Scholar
  27. 27.
    Masashi K, Daoyan W, Qiang L, Zhiliang J, Jaffer A, Xiangdong L, et al. Loss of krüppel-like factor 4 expression contributes to Sp1Overexpression and human gastric cancer development and progression. Hum Cancer Biol. 2006;12:6395–402.Google Scholar
  28. 28.
    Rowland BD, Bernards R, Peeper DS. The KLF4 tumor suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol. 2005;7(11):1074–82.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Malek Hossein Asadi
    • 1
    • 2
  • Ali Derakhshani
    • 1
  • Seyed Javad Mowla
    • 2
  1. 1.Department of Biotechnology, Institute of Science and High Technology and Environmental SciencesGraduate University of Advanced TechnologyKermanIran
  2. 2.Department of Molecular Genetics, Faculty of Biological SciencesTarbiat Modares UniversityTehranIran

Personalised recommendations